US 8420816
Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
granted A61KA61K31/4375A61K31/4545
Quick answer
US patent 8420816 (Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK) held by Takeda Pharmaceutical Company Limited expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4375, A61K31/4545, A61K31/496, A61K31/506